| Stem definition | Drug id | CAS RN |
|---|---|---|
| 846 | 51-49-0 |
| Dose | Unit | Route |
|---|---|---|
| 4 | mg | O |
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| April 14, 1967 | FDA | ABBVIE |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | C10AX01 | CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS LIPID MODIFYING AGENTS, PLAIN Other lipid modifying agents |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Hyperlipidemia | indication | 55822004 | DOID:1168 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 2.08 | acidic |
| pKa2 | 6.63 | acidic |
| pKa3 | 8.6 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Thyroid hormone receptor | Nuclear hormone receptor | AGONIST | CHEMBL | CHEMBL | |||||
| Thyroid hormone receptor beta | Transcription factor | IC50 | 7.46 | CHEMBL | |||||
| Glutamate NMDA receptor | Ion channel | IC50 | 6.48 | CHEMBL |
| ID | Source |
|---|---|
| 4022400 | VUID |
| N0000020406 | NUI |
| D03750 | KEGG_DRUG |
| 227544 | RXNORM |
| 4018501 | VANDF |
| 4022400 | VANDF |
| C0011824 | UMLSCUI |
| CHEBI:30659 | CHEBI |
| CHEMBL559 | ChEMBL_ID |
| CHEMBL3545058 | ChEMBL_ID |
| D003918 | MESH_DESCRIPTOR_UI |
| DB00509 | DRUGBANK_ID |
| 6951 | IUPHAR_LIGAND_ID |
| 7054-08-2 | SECONDARY_CAS_RN |
| 4W9K63FION | UNII |
| 8730 | PUBCHEM_CID |
| 308 | MMSL |
| 4569 | MMSL |
| d00747 | MMSL |
| 002055 | NDDF |
| 004779 | NDDF |
| 59170000 | SNOMEDCT_US |
| 61899008 | SNOMEDCT_US |
| 847003 | SNOMEDCT_US |
| CHEMBL1200777 | ChEMBL_ID |
None